Tetracaine
This local anesthetic is used to numb specific areas of the body before medical procedures, and is commonly used as eye drops before eye examinations or minor eye surgery, as well as in spinal anesthesia. It works by blocking nerve signals in the targeted area to prevent pain sensation. It acts more slowly but longer than some other local anesthetics.
Peso Molecular
264,3600 g/mol
LogP
3,70
TPSA
41,60 Ų
Regra dos 5 de Lipinski
Aprovado
Áreas Terapêuticas
Mecanismo de Ação
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Estrutura 2D
Cite this structure
Embed this structure
SMILES
CCCCNc1ccc(C(=O)OCCN(C)C)cc1
InChI
InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3
Molecular Formula
C15H24N2O2
HBD / HBA
1 / 4
Ligações Rotacionáveis
9
Átomos Pesados
19
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
This local anesthetic is used to numb specific areas of the body before medical procedures, and is commonly used as eye drops before eye examinations or minor eye surgery, as well as in spinal anesthesia. It works by blocking nerve signals in the targeted area to prevent pain sensation. It acts more slowly but longer than some other local anesthetics.
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Yes, Tetracaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL698. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5411. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tetracaine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tetracaine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tetracaine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tetracaine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tetracaine"></drugfyi-drug>